NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»21/05/2010 [Industry news]
Chiltern announces new offices in APAC

Chiltern International, a global contract research organisation (CRO) has announced its expansion plans in Asia Pacific.

Chiltern International, a global contract research organisation (CRO) has announced its expansion plans in Asia Pacific. Chiltern has established two new offices and launched operations in Australia and Singapore, with Singapore acting as the hub for its operations in Southeast Asia. This builds further upon Chiltern’s well established operation in India. Chiltern is also in the process of forming a company and establishing operations in China. Chiltern’s Asia Pacific operations will be led by Umakanta Sahoo, Executive Director, Asia Pacific. Commenting on the growth, “Chiltern’s expansion will provide a broad platform from which global pharmaceutical and biotech sponsors can expand their geographic reach with confidence and enhance patient recruitment in the Asia Pacific region,” stated Dr. Sahoo. Dr. Sahoo added, “Chiltern has been serving Asia for five years with offices in India and we recently completed centralizing our workforce into a new larger office location in Mumbai. We have built a strong foundation in all areas of clinical development services from which to grow further in the region.” Glenn Kerkhof, Chiltern CEO, stated, “Asia Pacific is one of the foremost emerging markets in our industry. With the current expansion of pharmaceutical R & D needs into the Asia Pacific region, Chiltern is well positioned to meet the needs this growth entails. We are very pleased to provide our clients with access to this market while extending our focus on the delivery of high quality, responsive and better value services to our customers.” Chiltern is currently recruiting experienced clinical staff and plans to grow its workforce in the Asia Pacific region to 70 by the end of 2010, providing full Clinical Development, Biometrics, and Resourcing Solutions services. To facilitate this growth, we are pleased to announce the appointment of Martin Painter as the Asia Pacific region’s Manager of Resourcing Solutions, Chiltern\'s business unit designed to offer fully integrated solutions to staffing needs. Martin will launch our recruitment and staffing services in the region and joins us from a leading life sciences recruitment company in Singapore.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.